Lisanne C C J Smans1, Pierre M J Zelissen. 1. Department of Internal Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, The Netherlands. l.c.c.j.smans@umcutrecht.nl
Abstract
OBJECTIVE: We earlier discovered partial recovery in a patient with autoimmune Addison's disease. The aim of this study was to assess the occurrence of adrenocortical recovery in patients with autoimmune adrenalitis. DESIGN: Cross-sectional study. PATIENTS: Twenty-seven adult patients with autoimmune Addison's disease on stable glucocorticoid and mineralocorticoid replacement therapy (RT) attending the Department of Endocrinology of a university teaching hospital were included in this study. METHODS: Adrenocortical function was assessed by performing an adrenocorticotrophic hormone (ACTH) (250 μg Synacthen) stimulation test (SST) after interruption of current glucocorticoid and mineralocorticoid RT. A normal adrenal response was defined as a serum cortisol concentration ≥500 nm 30 or 60 min after stimulation. Partial recovery was defined as a cortisol concentration ≥100 and ≤500 nm after stimulation. RESULTS: In 17 patients (63%), serum cortisol concentrations remained undetectable 30 and 60 min after the administration of ACTH. None of the remaining 10 participants had a normal response. Only one patient reached a cortisol concentration of 100 nm after 60 min, but this could not be confirmed during a second SST. CONCLUSIONS: In this cross-sectional study among 27 patients with autoimmune adrenalitis, no new cases of adrenocortical recovery were found.
OBJECTIVE: We earlier discovered partial recovery in a patient with autoimmune Addison's disease. The aim of this study was to assess the occurrence of adrenocortical recovery in patients with autoimmune adrenalitis. DESIGN: Cross-sectional study. PATIENTS: Twenty-seven adult patients with autoimmune Addison's disease on stable glucocorticoid and mineralocorticoid replacement therapy (RT) attending the Department of Endocrinology of a university teaching hospital were included in this study. METHODS:Adrenocortical function was assessed by performing an adrenocorticotrophic hormone (ACTH) (250 μg Synacthen) stimulation test (SST) after interruption of current glucocorticoid and mineralocorticoid RT. A normal adrenal response was defined as a serum cortisol concentration ≥500 nm 30 or 60 min after stimulation. Partial recovery was defined as a cortisol concentration ≥100 and ≤500 nm after stimulation. RESULTS: In 17 patients (63%), serum cortisol concentrations remained undetectable 30 and 60 min after the administration of ACTH. None of the remaining 10 participants had a normal response. Only one patient reached a cortisol concentration of 100 nm after 60 min, but this could not be confirmed during a second SST. CONCLUSIONS: In this cross-sectional study among 27 patients with autoimmune adrenalitis, no new cases of adrenocortical recovery were found.
Authors: Simon H S Pearce; Anna L Mitchell; Stuart Bennett; Phil King; Sukesh Chandran; Sath Nag; Shu Chen; Bernard Rees Smith; John D Isaacs; Bijay Vaidya Journal: J Clin Endocrinol Metab Date: 2012-07-05 Impact factor: 5.958
Authors: Catherine Napier; Kathleen Allinson; Earn H Gan; Anna L Mitchell; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Simon H S Pearce Journal: J Clin Endocrinol Metab Date: 2020-07-01 Impact factor: 5.958
Authors: Catherine Napier; Earn H Gan; Anna L Mitchell; Lorna C Gilligan; D Aled Rees; Carla Moran; Krishna Chatterjee; Bijay Vaidya; R Andrew James; Yaasir Mamoojee; Simon Ashwell; Wiebke Arlt; Simon H S Pearce Journal: J Clin Endocrinol Metab Date: 2020-04-01 Impact factor: 5.958
Authors: Annet Vulto; Ragnhildur Bergthorsdottir; Martijn van Faassen; Ido P Kema; Gudmundur Johannsson; André P van Beek Journal: Clin Endocrinol (Oxf) Date: 2019-06-20 Impact factor: 3.478